Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

S&P 500 Slumps as Worries Over Consumer Grow After Retail Sales Slide

Published 08/17/2021, 01:17 PM
Updated 08/17/2021, 03:58 PM
© Reuters.

By Yasin Ebrahim

Investing.com – The S&P 500 fell Tuesday, led by a fall in consumer discretionary stocks following weaker quarterly results from Home Depot and worries about the consumer amid data showing retail sales slipped to a two-month low.

The S&P 500 fell 0.7%, the Dow Jones Industrial Average slumped 0.9%, or 302 points, the Nasdaq was down 0.95%.

Retail sales dropped 1.1% in July, more than the 0.3% decline expected, paced by a fall in spending on autos, building materials, and nonstore retailers.  

 "There are two caveats, however. Since April, there has been a consistent pattern of upward revisions to retail sales, so it's possible that the momentum will improve with the next release," Jefferies (NYSE:JEF) said in a note.

Cyclicals including industrials, materials, and consumer discretionary were in the red, with the latter down more than 2% amid pressure from retailers including Amazon (NASDAQ:AMZN), and Home Depot.

Home Depot (NYSE:HD) fell more than 4% after reporting weaker-than-expected second-quarter comparable same store sales that offset quarterly results that beat on both top and bottom lines.

"While big ticket demand continues to outpace supply in some categories, slowing demand in smaller-ticket categories is likely a leading indicator to slowing comp growth in the future, keeping us sidelined on HD," Wedbush said in a note.

Walmart (NYSE:WMT) raised its full-year guidance after reporting better-than-expected second-quarter results. Its shares were down about 0.3%.

Technology stocks, meanwhile, struggled to replicate their positive start to the week, falling 1%, as megacap tech traded in the red.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT, Facebook (NASDAQ:FB), and Google-parent Alphabet (NASDAQ:GOOGL) were below the flatline.

Health care stocks shrugged off the broader market malaise, led by a 5% surge in Moderna (NASDAQ:MRNA).

The U.K. on Tuesday approved the use of the Moderna's Covid-19 vaccine for 12- to 17-year-olds.

Other vaccine stocks including Pfizer (NYSE:PFE), and Novavax (NASDAQ:NVAX) were also higher on the day.

Latest comments

300 point S&P slump, 1,000-point (or more) Dow and NQ washout coming. Happy investing in the Covid renaissance era, everyone.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.